Cancer Center conducts Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

M.D. Anderson Cancer Center is starting a new clinical trial of Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer.

This study develops infertility survey among reproductive age women with gynecological and breast cancer. This study aims to learn how women consider whether or not to try to have a baby after surviving cancer. The advice gathered from this survey may be shared with patients and survivors in the future, so that they have information to inform their decisions about cancer treatment and family planning.

The clinical trial started in April 1, 2019 and will continue throughout August 1, 2022.

The patients attend an audiotaped focus group over 90 minutes to provide feedback for survey development and complete an online survey over 15-30 minutes at baseline and 2 days late

The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the US and one of the original three comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located at the Texas Medical Center in Houston. It is affiliated with The University of Texas Health Science Center at Houston.

The contacts and locations are the M D Anderson Cancer Center, Houston, Texas, United States.

For more details: https://ichgcp.net/clinical-trials-registry/NCT04678414